Posted on May 19, 2017
AgriLabs® today announced the introduction of a new innovative custom vaccine option for swine veterinarians and producers. AgriLabs custom vaccines combine the benefits of herd-specific autogenous vaccines with proprietary production processes and ENABL® adjuvant technology designed to improve vaccine performance.
Posted on May 10, 2017
AgriLabs® today announced it has received a U.S. patent for ENABL® adjuvant technology and its use as a delivery system for the DNA vaccines the company is developing. The patent covers a broad range of adjuvant compositions and methods for human and animal health.
Posted on May 05, 2017
US firm AgriLabs® is nearing commercialization of the first DNA vaccine platform for food animals in the US market.
Posted on April 21, 2017
Speaking at the prestigious World Vaccine Congress recently held in Washington, D.C., the lead research scientist for AgriLabs offered insights for moving a vaccine from research to commercial production using the company’s DNA vaccine platform as an example.
Posted on April 18, 2017
A new vaccine based on Siderophore Receptor and Porin (SRP®) technology is showing considerable promise in reducing Klebsiella mastitis in dairy cows, based on data from an Iowa State University trial shared at the recent Academy of Veterinary Consultants spring conference in Dallas.